Director/PDMR Shareholding
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases, announces the sale of certain shares by members of executive management and non-executive directors ("PDMRs") pursuant to its recently completed Tender Offer.
The Company's total issued ordinary share capital is 257,927,489 shares, 18,608,909 shares of which are held in treasury by the Company.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Eric Elenko John LaMattina Robert Langer |
| 2 | Reason for the notification | |
| a) | Position/status | Eric Elenko: President John LaMattina: Non-Executive Director Robert Langer: Non-Executive Director |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| b) | Nature of the transaction | Sale of ordinary shares pursuant to Company's recently completed Tender Offer. |
| c) | Price(s) and volume(s) | Individual Price Volume Eric Elenko 2.50 GBP 479,553 ordinary shares John LaMattina 2.50 GBP 54,882 ordinary shares Robert Langer 2.50 GBP 233,098 ordinary shares |
| e) | Date of the transaction | 24 June 2024 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.